Waved-1 mutant mice are hypersensitive to the locomotor actions of cocaine

Synapse

Volumn 61, Issue 4, 2007, Pages 259-262

  Stanwood, Gregg D ^a,b,c   Levitt, Pat ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Jumping; Mouse; Stereotypy; Striatum; Transforming growth factor ; Wa 1

Indexed keywords

BIOGENIC AMINE; COCAINE; PSYCHOSTIMULANT AGENT; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERSENSITIVITY; JUMPING; LIMBIC CORTEX; LOCOMOTION; MALE; MOUSE; MOUSE MUTANT; NERVE CELL DIFFERENTIATION; NEUROANATOMY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; STEREOTYPY; STRESS;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE UPTAKE INHIBITORS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOTOR ACTIVITY; STEREOTYPED BEHAVIOR; WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY;

EID: 33847002361     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20364     Document Type: Article

References (43)

1. Airavaara M, Planken A, Gaddnas H, Piepponen TP, Saarma M, Ahtee L. 2004. Increased extracellular dopamine concentrations
2. and FosB/ΔFosB expression in striatal brain areas of heterozygous GDNF knockout mice. Eur J Neurosci 20:2336-2344.
3. Anchan RM, Reh TA, Angello J, Balliet A, Walker M. 1991. EGF and TGF-α stimulate retinal neuroepithelial cell proliferation in vitro. Neuron 6:923-936.
4. Andersen SL. 2003. Trajectories of brain development: Point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27(1/2):3-18.
5. Berhow MT, Russell DS, Terwilliger RZ, Beitner-Johnson D, Self DW, Lindsay RM, Nestler EJ. 1995. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68:969-979.
6. Berhow MT, Hiroi N, Kobierski LA, Hyman SE, Nestler EJ. 1996. Influence of cocaine on the JAK-STAT pathway in the mesolimbic dopamine system. J Neurosci 16:8019-8026.
7. Berkowitz EA, Seroogy KB, Schroeder JA, Russell WE, Evans EP, Riedel RF, Phillips HK, Harrison CA, Lee DC, Luetteke NC. 1996. Characterization of the mouse transforming growth factor α gene: Its expression during eyelid development and in waved 1 tissues. Cell Growth Differ 7:1271-1282.
8. Blum M. 1998. A null mutation in TGF-α leads to a reduction in midbrain dopaminergic neurons in the substantia nigra. Nat Neurosci 1:374-377.
9. Borgundvaag B, Kudlow JE, Mueller SG, George SR. 1992. Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-α gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 130:3453-3458.
10. Burrows RC, Wancio D, Levitt P, Lillien L. 1997. Response diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex. Neuron 19:251-267.
11. Burrows RC, Levitt P, Shors TJ. 2000. Postnatal decrease in transforming growth factor a is associated with enlarged ventricles, deficient amygdaloid vasculature and performance deficits. Neuroscience 96:825-836.
12. Essman WD, McGonigle P, Lucki I. 1993. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology 112:233-241.
13. Filip M, Faron-Gorecka A, Kusmider M, Golda A, Frankowska M, Dziedzicka-Wasylewska M. 2006. Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal. Brain Res 1071:218-225.
14. Freeman AY, Pierce RC. 2002. Neutralization of neutrophin-3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine-induced behavioral plasticity in rats. Synapse 46:57-65.
15. Green-Sadan T, Kuttner Y, Lublin-Tennenbaum T, Kinor N, Boguslavsky Y, Margel S, Yadid G. 2005. Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats. Exp Neurol 194:97-105.
16. Grimm JW, Lu L, Hayashi T, Hope BT, Su TP, Shaham Y. 2003. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: Implications for incubation of cocaine craving. J Neurosci 23:742-747.
17. Hall FS, Drgonova J, Goeb M, Uhl GR. 2003. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 28:1485-1490.
18. Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR. 1999. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 19:4110-4122.
19. Junier MP. 2000. What role(s) for TGFα in the central nervous system? Prog Neurobiol 62:443-473.
20. Kornblum HI, Hussain RJ, Bronstein JM, Gall CM, Lee DC, Seroogy KB. 1997, Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming growth factor a, in the rat brain. J Comp Neurol 380:243-261.
21. Koshibu K, Levitt P. 2005. Sex differences in expression of transforming growth factor-α and epidermal growth factor receptor mRNA in waved-1 and C57B16 mice. Neuroscience 134:877-887.
22. Koshibu K, Levitt P. 2006. Transforming growth factor-α induces sex-specific neurochemical imbalance in the stress- and memory-associated brain structures. Neuropharmacology 50:807-813.
23. Koshibu K, Levitt P, Ahrens ET. 2004. Sex-specific, postpuberty changes in mouse brain structures revealed by three-dimensional magnetic resonance microscopy. Neuroimage 22:1636-1645.
24. Koshibu K, Ahrens ET, Levitt P 2005. Postpubertal sex differentiation of forebrain structures and functions depend on transforming growth factor-α. J Neurosci 25:3870-3880.
25. Laviola G, Adriani W, Terranova ML, Gerra G. 1999. Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci Biobehav Rev 23:993-1010.
26. Levitt P, Eagleson KL, Chan AV, Ferri RT, Lillien L. 1997. Signaling pathways that regulate specification of neurons in developing cerebral cortex. Dev Neurosci 19:6-8.
27. Lillien L. 1998. Neural progenitors and stem cells: Mechanisms of progenitor heterogeneity. Curr Opin Neurobiol 8:37-44.
28. Lillien L, Cepko C. 1992. Control of proliferation in the retina: Temporal changes in responsiveness to FGF and TGF α. Development 115:253-266.
29. Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y. 2004. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24:1604-1611.
30. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC. 1993. TGF α deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263-278.
31. Ma YJ, Junier MP, Costa ME, Ojeda SR. 1992. Transforming growth factor-α gene expression in the hypothalamus is developmentally regulated and linked to sexual maturation. Neuron 9:657-670.
32. Ma YJ, Costa ME, Ojeda SR. 1994. Developmental expression of the genes encoding transforming growth factor α and its receptor in the hypothalamus of female rhesus macaques. Neuroendocrinology 60:346-359.
33. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR. 1993. Mice with a null mutation of the TGF α gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73:249-261.
34. Meaney MJ, Brake W, Gratton A. 2002. Environmental regulation of the development of mesolimbic dopamine systems: A neurobiological mechanism for vulnerability to drug abuse? Psychoneuroendocrinology 27(1/2):127-138.
35. Santa-Olalla J, Covarrubias L. 1995, Epidermal growth factor (EGF), transforming growth factor-α (TGF-α), and basic fibroblast growth factor (bFGF) differentially influence neural precursor cells of mouse embryonic mesencephalon. J Neurosci Res 42:172-183; erratum in J Neurosci Res 1995;42:855.
36. Seroogy KB, Lundgren KH, Lee DC, Guthrie KM, Gall CM. 1993. Cellular localization of transforming growth factor-α mRNA in rat forebrain. J Neurochem 60:1777-1782.
37. Solbrig MV, Koob GF, Parsons LH, Kadota T, Horscroft N, Briese T, Lipkin WI, 2000. Neurotrophic factor expression after CNS viral injury produces enhanced sensitivity to psychostimulants: Potential mechanism for addiction vulnerability. J Neurosci 20:RC104.
38. Spear LP 2000. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463.
39. Thadani PV 2002. The intersection of stress, drug abuse and development. Psychoneuroendocrinology 27(1/2):221-230.
40. Tucker MS, Khan I, Fuchs-Young R, Price S, Steininger TL, Greene G, Wainer BH, Rosner MR. 1993. Localization of immunoreactive epidermal growth factor receptor in neonatal and adult rat hippocampus. Brain Res 631:65-71.
41. Weickert CS, Blum M. 1995. Striatal TGF-α: Postnatal developmental expression and evidence for a role in the proliferation of subependymal cells. Brain Res Dev Brain Res 86(1/2):203-216.
42. Xian CJ, Zhou XF. 1999. Roles of transforming growth factor-α and related molecules in the nervous system. Mol Neurobiol 20(2/3):157-183.
43. Zhang JM, Dix J, Langtimm-Sedlak CJ, Trusk T, Schroeder B, Hoffmann R, Strosberg AD, Winslow JW, Sieber-Blum M. 1997. Neurotrophin-3- and norepinephrine-mediated adrenergic differentiation and the inhibitory action of desipramine and cocaine. J Neurobiol 32:262-280.